Articles
$1.4 million to advance Australian biomedical research
The 2015 recipients of the Ramaciotti Awards for Biomedical Research, distributed by the Clive and Vera Ramaciotti Foundations, have been revealed.
[ + ]Breast cancer vaccine completes preclinical proof-of-concept study
Breast cancer vaccine candidate OQR200, developed by OncoQR, has successfully completed a proof-of-concept study in non-human primates (NHPs).
[ + ]Calibration and adjustment of humidity instruments: pros and cons of different methods
There are many ways to approach the calibration and adjustment of relative humidity instruments. Some of the most common methods will be described in this article, along with their advantages and disadvantages.
[ + ]Phosphagenics restructure effective immediately
Drug delivery company Phosphagenics has announced a corporate restructure, effective immediately, following its recent strategic review. [ + ]
Why don't elephants get cancer?
US researchers may have solved an intriguing mystery — why do elephants rarely get cancer? [ + ]
Gene variant increases depression risk for abused children
Scientists have produced further evidence linking a particular variant of the brain's serotonin transporter (SERT) gene to an increased risk of severe depression in individuals who suffered abuse as children. [ + ]
Automated plate assessment system exceeds expectations
Shares in LBT Innovations rose almost 20% as the medical technology company received successful results from a clinical trial of its culture plate analysis technology. [ + ]
The risky business of cell culture
The process of cell culture is one which can be beneficial for modelling health and disease but is not without its risks — risks which many scientists are often willing to take.
[ + ]Paranta Biosciences commences cystic fibrosis trial
Paranta Biosciences has successfully closed a $7 million financing round, which it will use to fund the development of treatments for inflammatory and fibrotic lung diseases. [ + ]
Laboratory market transformation drives systems innovation
The fast-changing laboratory market is ripe for a new generation of information systems that meet the needs of a modern pathology environment.
[ + ]The bubonic plague — 20 million years in the making?
Entomology researcher George Poinar, Jr has unearthed what he believes is a 20-million-year-old strain of the bubonic plague.
[ + ]US$53.9m for Avita to support mass burn injuries
Avita Medical has been awarded a contract with BARDA, worth up to $53.9 million, which supports late-stage clinical development and procurement of Avita's ReCell autologous cell harvesting device under a mass casualty preparedness program. [ + ]
Trialled in the wild — the Tasmanian devil vaccine
Nineteen Tasmanian devils, who were recently immunised against the deadly devil facial tumour disease (DFTD), have been released into Narawntapu National Park as part of a program to test the vaccine in the wild for the very first time. [ + ]
No snow-white apple fairytale for Australia
A Canadian company has begun marketing two non-browning apple varieties that employ CSIRO's patented gene-silencing technology. But in GM-averse Australia, there are no takers — why? [ + ]
The Daraprim price hike and the TPP
After a tumultuous week for Turing Pharmaceuticals — which saw the company raise the price of an essential medicine by over 4000%, only to lower it again in the face of universal criticism — an Australian intellectual property expert warns that similar incidents could occur as a result of the Trans-Pacific Partnership (TPP).
[ + ]
